Back to search

France· FR:62175120

CLOPIDOGREL/ACIDE ACETYLSALICYLIQUE EG 75 mg/75 mg, comprimé pelliculé

A medicinal product containing acide acétylsalicylique + hydrogénosulfate de clopidogrel, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCLOPIDOGREL/ACIDE ACETYLSALICYLIQUE E…ATC—REGISTER NO.FR:62175120PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACIDE ACÉTYLSALICYLIQUE + HYDROGÉNOSULFATE DE CLOPIDOGREL
Manufacturer
EG LABO - LABORATOIRES EUROGENERICS
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930300800
    plaquette(s) OPA : polyamide orienté aluminium polyéthylène de 30 comprimé(s)
    EUR 5.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acide acétylsalicylique + hydrogénosulfate de clopidogrel in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acide acétylsalicylique + hydrogénosulfate de clopidogrel products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Bulgaria · Клопидогрел/Ацетилсалицилова Киселина Msn, Плакекс Комби
  • Czechia · Qydaxer Duo
  • Germany · Clopidogrel/Acetylsalicylsäure Vivanta
  • Estonia · Clopidogrel/Acetylsalicylic Acid Msn
  • Spain · Clopidogrel/Ácido Acetilsalicílico Vivanta
  • Hungary · Clopidogrel/Acetylsalicylic Acid Msn
  • Iceland · Clopidogrel/Acetylsalicylic Acid Doc, Clopidogrel/Acetylsalicylic Acid Msn Labs Europe Limited
  • Italy · Clopidogrel E Acido Acetilsalicilico Aurobindo, Clopidogrel E Acido Acetilsalicilico Doc
  • Liechtenstein · Clopidogrel/Acetylsalicylic Acid Viatris, Duoplavin
  • Lithuania · Clopidogrel/Acetylsalicylic Acid Msn
  • Latvia · Clopidogrel/Acetylsalicylic Acid Msn
  • Norway · Clopidogrel/Acetylsalicylic Acid Viatris, Duoplavin
  • Poland · Auroclasa, Clopidogrel/Acetylsalicylic Acid Msn
  • Portugal · Auroclasa, Clopidogrel + Ácido Acetilsalicílico Generis
  • Romania · Clopidogrel/Acid Acetilsalicilic Msn
  • Slovakia · Clopidogrel/Acetylsalicylic Acid Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/082c1394-d984-4ba4-9e78-a4b0d8e802ac
GET /v1/drugs/082c1394-d984-4ba4-9e78-a4b0d8e802ac?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62175120",
  "date_amm": "2024-07-30",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ACIDE ACÉTYLSALICYLIQUE + HYDROGÉNOSULFATE DE CLOPIDOGREL",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about acide acétylsalicylique + hydrogénosulfate de clopidogrel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.